Results 101 to 110 of about 7,378 (198)

Not Your Typical Vaginal Bleed: Inflammatory Bowel Disease in a Sigmoid Neovagina. [PDF]

ACG Case Rep J
Zaffar D, McCabe MJ, Patel DM, Daniels DK.   +3 more
europepmc   +1 more source

Acute pancreatitis associated with mesalamine: A case report and review of the literature

, 1996
Mesalamine, widely used in the treatment of chronic inflammatory bowel disease, has been associated in some patients with the development of acute pancreatitis.
GALLERANI M., BARIANI L., MANFREDINI, Roberto, CHIERICI F., FRANCESCHINI F., LA CECILIA O., SCIRE' RISICHELLA I., MIRIZIO A. M., NOTARSTEFANO P., TASSI A., FERSINI C., RIZZIOLI E.   +11 more
core  

Mesalazine-induced nephrolitiasis and crystalluria. [PDF]

Urol Case Rep
Prieto RM, Julià F, Ordoñez FA, Costa-Bauzà A, Cabeza A, Muñoz M, Grases F.   +6 more
europepmc   +1 more source

Acute Pleuritis Caused by Mesalamine

Internal Medicine, 2016
Imai, Jin, Suzuki, Takayoshi, Tsuda, Shingo, Mine, Tetsuya   +3 more
openaire   +3 more sources

Associations Between Depression and Gastrointestinal Disorders in a Large Real-World Cohort. [PDF]

Cureus
Gong TM, Li Z, Mula M, Espiridion E.
europepmc   +1 more source

Management of Ulcerative Colitis after Mesalamine-Induced Myocarditis: Successful Treatment with Upadacitinib - A Case Report. [PDF]

Inflamm Intest Dis
Tanaka T, Nakashima T, Kinugasa M.
europepmc   +1 more source

Balancing Act: Lessons From Comanaging Patients With Inflammatory Bowel Disease and HIV/AIDS. [PDF]

ACG Case Rep J
Cruz Grave E, Paik P, Kim J, Odufalu FD.
europepmc   +1 more source

Semaglutide-Induced Symptomatic Remission in Ulcerative Colitis. [PDF]

ACG Case Rep J
Alqinai B, Adeniran O, Adekolu A, Gayam S.   +3 more
europepmc   +1 more source

Design and biological evaluation of mesalamine-NSAID hybrids targeting the NLRP3 inflammasome: a multi-target strategy for ulcerative colitis therapy. [PDF]

Sci Rep
Yahya M, Safaei-Ghomi J, Haghir-Ebrahimabadi A, Jalali H, Mojtabazadeh H.   +4 more
europepmc   +1 more source

pH-responsive hyaluronic acid-co-poly(acrylic acid) hydrogel scaffolds for modified release of mesalamine; characterization and biosafety evaluation. [PDF]

RSC Adv
Liaqat H, Minhas MU, Badshah SF, Barkat K, Khan S, Chopra S, Chopra H, Alyami EM, Metouekel A, Asrat Mengistie A, Elossaily GM, Shahid M.   +11 more
europepmc   +1 more source